ACLARION, INC. Interest Expense
ACLARION, INC. (ACON) reported Interest Expense of $64.08 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2025-04-09.
Financial Statements › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2025-04-09
- ACLARION, INC. interest expense for the quarter ending 2024-03-31 was $335.82K, a 24235.07% increase year-over-year.
- ACLARION, INC. interest expense for the quarter ending 2023-12-31 was -$104.33K, a 5142.29% decline year-over-year.
- ACLARION, INC. interest expense for the quarter ending 2023-09-30 was $166.33K, a 7935.36% increase year-over-year.
- ACLARION, INC. interest expense for the quarter ending 2023-06-30 was $47.14K, a 96.48% decline year-over-year.
- ACLARION, INC. interest expense for fiscal 2024 was $64.08K, a 42.02% decline from fiscal 2023.
- ACLARION, INC. interest expense for fiscal 2023 was $110.53K, a 92.67% decline from fiscal 2022.
- ACLARION, INC. interest expense for fiscal 2022 was $1.51M, a 217.44% increase from fiscal 2021.
- ACLARION, INC. interest expense for fiscal 2021 was $474.91K.
| Period end | Interest Expense 3 month | Interest Expense 3 month as first filed | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month | Interest Expense 12 month as first filed |
|---|---|---|---|---|---|---|
| 2024-12-31 | $64.08K 10-K · filed 2025-04-09 | |||||
| 2024-03-31 | $335.82K 10-Q · filed 2024-05-15 | $231.50K derived: sum of 2 quarters · filed 2025-04-09 | $397.83K derived: sum of 3 quarters · filed 2025-04-09 | $444.97K derived: sum of 4 quarters · filed 2025-04-09 | ||
| 2023-12-31 | -$104.33K derived: 10-K 12 month − 10-Q 9 month · filed 2025-04-09 | $62.01K derived: sum of 2 quarters · filed 2025-04-09 | $109.15K derived: sum of 3 quarters · filed 2025-04-09 | $110.53K 10-K · filed 2025-04-09 | $608.29K 10-K · filed 2024-03-28 | |
| 2023-09-30 | $166.33K 10-Q · filed 2023-11-14 | $213.47K derived: sum of 2 quarters · filed 2023-11-14 | $214.85K 10-Q · filed 2023-11-14 | $216.92K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-06-30 | $47.14K 10-Q · filed 2023-08-25 | $48.52K 10-Q · filed 2023-08-25 | $50.59K derived: sum of 3 quarters · filed 2024-05-15 | $52.66K derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2023-03-31 | $1.38K 10-Q · filed 2024-05-15 | $3.45K derived: sum of 2 quarters · filed 2024-05-15 | $5.52K derived: sum of 3 quarters · filed 2024-05-15 | $1.35M derived: sum of 4 quarters · filed 2024-05-15 | ||
| 2022-12-31 | $2.07K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $4.14K derived: sum of 2 quarters · filed 2024-03-28 | $1.34M derived: sum of 3 quarters · filed 2024-03-28 | $1.51M 10-K · filed 2024-03-28 | ||
| 2022-09-30 | $2.07K 10-Q · filed 2023-11-14 | $1.34M derived: sum of 2 quarters · filed 2023-11-14 | $1.51M 10-Q · filed 2023-11-14 | $1.67M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $1.34M 10-Q · filed 2023-08-25 | $1.34M 10-Q · filed 2022-08-15 | $1.50M 10-Q · filed 2023-08-25 | $1.67M derived: sum of 3 quarters · filed 2023-08-25 | $1.84M derived: sum of 4 quarters · filed 2023-08-25 | |
| 2022-03-31 | $162.74K 10-Q · filed 2023-07-03 | $329.98K derived: sum of 2 quarters · filed 2023-07-03 | $497.61K derived: sum of 3 quarters · filed 2023-07-03 | $580.44K derived: sum of 4 quarters · filed 2023-07-03 | ||
| 2021-12-31 | $167.24K derived: 10-K/A 12 month − 10-Q 9 month · filed 2023-06-12 | $334.87K derived: sum of 2 quarters · filed 2023-06-12 | $417.70K derived: sum of 3 quarters · filed 2023-06-12 | $474.91K 10-K/A · filed 2023-06-12 | ||
| 2021-09-30 | $167.63K 10-Q · filed 2022-11-14 | $250.46K derived: sum of 2 quarters · filed 2022-11-14 | $307.67K 10-Q · filed 2022-11-14 | |||
| 2021-06-30 | $82.83K 10-Q · filed 2022-08-15 | $140.04K 10-Q · filed 2022-08-15 | ||||
| 2021-03-31 | $57.21K 10-Q · filed 2022-06-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| BioNexus Gene Lab Corp (BGLC) | $0.004B | ||
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Fulgent Genetics, Inc. (FLGT) | United States | $0.593B | -6.70 |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |